公开(公告)号：US10017575B2

公开(公告)日：2018-07-10

申请号：US15242135

申请日：2016-08-19

Applicant: UCB Pharma S.A.

Inventor： Alastair David Griffiths Lawson ,  Andrew Malcolm Nesbitt ,  Andrew George Popplewell ,  Stevan Graham Shaw ,  Diana Shpektor ,  Yi Zhang

IPC: C07K16/18 ,  C07K16/28 ,  A61K39/395 ,  A61K45/06 ,  C07K14/705 ,  A61K39/00

CPC classification number: C07K16/2878 ,  A61K39/3955 ,  A61K45/06 ,  A61K2039/505 ,  C07K14/70578 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/55 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

公开(公告)号：US20160355598A1

公开(公告)日：2016-12-08

申请号：US15242135

申请日：2016-08-19

Applicant: UCB Pharma S.A.

Inventor： Alastair David Griffiths Lawson ,  Andrew Malcolm Nesbitt ,  Andrew George Popplewell ,  Stevan Graham Shaw ,  Diana Shpektor ,  Yi Zhang

IPC: C07K16/28

CPC classification number: C07K16/2878 ,  A61K39/3955 ,  A61K45/06 ,  A61K2039/505 ,  C07K14/70578 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/55 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

公开(公告)号：US09428570B2

公开(公告)日：2016-08-30

申请号：US13973189

申请日：2013-08-22

Applicant: UCB PHARMA S.A.

Inventor： Alastair David Griffiths Lawson ,  Andrew Malcolm Nesbitt ,  Andrew George Popplewell ,  Stevan Graham Shaw ,  Diana Shpektor ,  Yi Zhang

IPC: A61K39/395 ,  C07K16/28 ,  C07K14/705 ,  A61K45/06 ,  A61K39/00

CPC classification number: C07K16/2878 ,  A61K39/3955 ,  A61K45/06 ,  A61K2039/505 ,  C07K14/70578 ,  C07K2317/24 ,  C07K2317/33 ,  C07K2317/55 ,  C07K2317/565 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.